Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Director
We wish to inform you that Mr. Mithun Mohan Jadhav, (DIN: 08181048) has vide his resignation letter dated 17 June, 2022 has resigned from the position of Whole time Director of the Company with immediate effect Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed copy of the Annual Secretarial Compliance Report dated April 26, 2022 issued by Shivam Sharma & Associates, for the financial year 2021-2022. This is for your information and record. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is the copy of Press Release titled 'LASA SECURES BULK ORDER OF ? 500 MILLION' issued by the Company. You are requested to note the above on your records. Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 please find enclosed herewith Disclosure of Related Party Transactions for the year ended March 31, 2022. You are requested to note the above on your records. Lasa Supergenerics Ltd - 540702 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLasa Supergenerics Ltd 2CINL24233MH2016PLC274202 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ankita Shetty Designation: Company Secretary and Compliance Officer EmailId: cs@lasalabs.com Name of the Chief Financial Officer: Ravi Shankar Kabra Designation: Chief Financial Officer EmailId: raviskabra.rsk@gmail.com Date: 25/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Lasa Supergenerics Ltd - 540702 - Compliances - YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015.
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Practicing Company Secretary for the year ended March 31, 2022. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
LASA SUPERGENERICS PAT AT 12.35 Cr up by Robust 362% as compared to Loss of 4.71 Cr in Q3FY22 Lasa Supergenerics Ltd - 540702 - Corporate Action-Board approves Dividend
Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting of the Company. Lasa Supergenerics Ltd - 540702 - Results-Financial Results For Year Ended March 31, 2022
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 10.30 a.m. and concluded at 12:45 p.m. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2022. 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting of the Company.
